GALWAY, Ireland, March 27, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ surgical system for cranial and ear, nose, and throat (ENT) procedures. Cleared for spine procedures in February, the Stealth AXiS™ surgical system … [Read More...] about Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
Main Content
BREAKING NEWS
SpinePoint Receives U.S. FDA 510(k) Clearance for Flex-Z™ Cervical Cage/ First Product in the Ultra-Low Stiffness Cushioning Interbody Platform
SpinePoint LLC announces U.S. FDA 510(k) clearance of the Flex-Z™ Cervical Cage (K252432) on March 25, 2026 — the first cleared product in an eight-device ultra low stiffness interbody platform protected by IP through 2043. Built from 3D-printed porous titanium, the Flex-Z™ is engineered to match cancellous bone stiffness in anterior cervical fusion RENO, Nev., March 27, … [Read More...] about SpinePoint Receives U.S. FDA 510(k) Clearance for Flex-Z™ Cervical Cage/ First Product in the Ultra-Low Stiffness Cushioning Interbody Platform
Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain
Exclusive agreement expands Medtronic's comprehensive pain interventions portfolio, increases treatment options for patients living with chronic pain GALWAY, Ireland, March 24, 2026 /PRNewswire/ -- Medtronic plc, a global leader in healthcare technology, today announced that it has entered into a distribution agreement with Merit Medical Systems, Inc. (NASDAQ: MMSI), to offer FDA-cleared … [Read More...] about Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain
ATEC’s Valence: Robotics in Service of a Procedural Strategy
ATEC is no longer just a fast-growing spine company adding another technology box to its portfolio. With $764 million in revenue in 2025, up 25% year over year, it is increasingly behaving like a company trying to build procedural control around the areas where it already believes it has competitive leverage. That is the real significance of Valence, ATEC’s robotic solution for spine … [Read More...] about ATEC’s Valence: Robotics in Service of a Procedural Strategy
VySpine Reaches 20th FDA Clearance with DiversiVy Facet Screw System
VySpine has received FDA 510(k) clearance for its new DiversiVy Facet Screw System, a device intended for use in the lumbosacral spine to provide stabilization and support fusion procedures. The clearance is another notable milestone for the company, which says this is its 20th FDA clearance in less than five years. For a relatively small player in the spine market, that pace of regulatory … [Read More...] about VySpine Reaches 20th FDA Clearance with DiversiVy Facet Screw System
The Regulatory Trap: FDA and MDR Are Milestones. They Are Not a Business Model
In medtech, including the spine business, few goals generate as much obsession as obtaining FDA clearance in the United States or CE marking under MDR in Europe. For many startups, that milestone eventually becomes the company’s central focus. Everything revolves around approval: the product, trials, documentation, investors, timelines, and resources. The problem is that many end up confusing … [Read More...] about The Regulatory Trap: FDA and MDR Are Milestones. They Are Not a Business Model
What Really Worries Surgeons About Subsidence? A practical industry perspective on what Cage Subsidence means in daily spine surgery
In spine surgery, cage subsidence is often framed as a radiographic complication or an implant-related event. Yet its real significance lies elsewhere. What makes subsidence important is not the image itself, but what it may reveal and what it may compromise. As the cage settles, disc height can decrease, indirect decompression may be reduced, segmental correction can be partially lost, and the … [Read More...] about What Really Worries Surgeons About Subsidence? A practical industry perspective on what Cage Subsidence means in daily spine surgery
BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease
New blinded data from ~45 patients to date in key pain and function scales and safety and tolerability of the Company’s proprietary hypoxic-cultured mesenchymal stem cells to be unveiled on March 28th at the 2026 Orthopaedic Research Society Annual Meeting MELVILLE, N.Y., March 19, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative,” “BRTX,” or the “Company”) … [Read More...] about BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease
First Subjects Randomized in Clinical Trial Evaluating the Benefits of Total Segmental Fusion in Treating Degenerative Conditions in the Lumbar Spine
PLEASANTON, Calif., March 19, 2026 /PRNewswire/ -- Providence Medical Technology, Inc., a pioneer in less invasive solutions for spine surgery, today announced enrollment of the first patients in its prospective, randomized controlled trial (RCT) evaluating the CORUS-LX System for the treatment of degenerative lumbosacral disease. This multi-center RCT will enroll subjects indicated … [Read More...] about First Subjects Randomized in Clinical Trial Evaluating the Benefits of Total Segmental Fusion in Treating Degenerative Conditions in the Lumbar Spine
Spinal Elements Expands Ventana® Platform with FDA 510(k) Clearance and First Cases of Ventana® A ALIF System
CARLSBAD, Calif., March 18, 2026 /PRNewswire/ -- Spinal Elements®, a spine technology company known for developing innovative surgical solutions that prioritize clinical performance and surgical efficiency, today announced 510(k) clearance from the FDA and the first cases using its Ventana A Anterior Lumbar Interbody Fusion (ALIF) System. Ventana A strengthens Spinal Elements' family of 3D printed … [Read More...] about Spinal Elements Expands Ventana® Platform with FDA 510(k) Clearance and First Cases of Ventana® A ALIF System
Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025
Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025 Financial Highlights Schlieren (Zurich), Switzerland, March 10, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced its financial and operational results for the full year 2025, marking another year of significant … [Read More...] about Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025
Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds
Study demonstrates cost savings and improved health outcomes associated with the use of CellerateRX® as an adjunct to the standard of care for high-risk spinal surgery patients, compared to the standard of care alone FORT WORTH, TX, March 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company … [Read More...] about Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds